BridgeMD

Sign in

Muscle Spasticity clinical trials

Explore recruiting muscle spasticity clinical trials.

Recruiting muscle spasticity studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Muscle Spasticity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, open-label, non-randomized, single-arm, dose titration study to investigate the efficacy and safety of IncobotulinumtoxinA in children deemed to require a total body dose up to 22U/kg (maximum dose 550U) during the study period for the treatment of upper and lower limb spasticity due to cerebral palsy. PROTOCOL CODE: INCIPIT

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A first-in-human (FIH) clinical trial to investigate the human monoclonal antibody NG004, administrated intrathecally in acute spinal cord injury (SCI) patients

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Riluzole for the treatment of spasticity in the traumatic chronic spinal cord injury condition: Adaptive, Multicenter, placebo-controlled, randomised, double blind trial in a Rare Disorder

France

Phase I and Phase II (Integrated)- Bioequivalence Study EU CTIS Study details

Exploratory study on the effect of Rimonabant on hand function in patients with spinal cord injury (RIMOHANDOPEN)

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Muscle Spasticity trials by city

Muscle Spasticity in Toronto Muscle Spasticity in Vancouver Muscle Spasticity in Montreal Muscle Spasticity in Calgary Muscle Spasticity in Edmonton Muscle Spasticity in Ottawa Muscle Spasticity in Winnipeg Muscle Spasticity in Quebec City Muscle Spasticity in Hamilton Muscle Spasticity in Kitchener Muscle Spasticity in London Muscle Spasticity in Halifax Muscle Spasticity in New York Muscle Spasticity in Los Angeles Muscle Spasticity in Chicago Muscle Spasticity in Houston